• Vivera Pharmaceuticals, Inc
• 21 Apr, 2022

Vivera Pharmaceuticals, Inc. is pleased to announce that it has received a Notice of Allowance for U.S. Patent Application No. 17/066,985 entitled, "Self-Contained, Portable, Sanitization Device and Telemedicine Station," for the Company's MDZone platform from the United States Patent and Trademark Office (USPTO). This Notice of Allowance indicates that the patent application has passed its examination for issuance.
Read more...